This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Huizar, J. F. Articles by Smith, H. S. Search for Related Content PubMed PubMed Citation Articles by Huizar, J. F. Articles by Smith, H. S.

Sulfonylureas attenuate electrocardiographic ST-segment elevation during an acute myocardial infarction in diabetics

Jose F. Huizar, MD^*,*, Luis A. Gonzalez, MD^*, James Alderman, MD, FACC and Harton S. Smith, MD, FACC

^* MetroWest Medical Center, Framingham, Massachusetts, USA
State University of New York, Upstate Medical University Hospital, Syracuse, New York, USA
Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
Heart Center of MetroWest, Framingham, Massachusetts, USA

View larger version (19K): [in a new window]   Figure 1 Non-diagnostic ST-segment elevation during acute myocardial infarction, subdivided by infarct size (total of 88 patients). White bars = control; black bars = sulfonylureas. CPK = creatinine phosphokinase.

View larger version (19K): [in a new window]   Figure 2 Non-diagnostic ST-segment elevation during acute myocardial infarction. Males (55 patients) compared with overall study population (88 patients) subdivided by infarct size. White bars = control; black bars = sulfonylureas. CPK = creatinine phosphokinase.